Samir Rashmikant Patel
Director, 10% Owner · Akari Therapeutics Plc
- 2024
- Jul 17, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Samir Rashmikant Patel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hoyoung Huh - $1.50M in AKTX purchases and sales in the last 12 months
- Abizer Gaslightwala - $437K in AKTX purchases and sales in the last 12 months
- Raymond Prudo-Chlebosz - $406K in AKTX purchases and sales in the last 12 months
- Sandip I. Patel - $162K in AKTX purchases and sales in the last 12 months
- Robert B. Bazemore - $62K in AKTX purchases and sales in the last 12 months
- Kameel D. Farag - $10K in AKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Samir Rashmikant Patel?
Samir Rashmikant Patel is a corporate insider, tracked as Director, 10% Owner of Akari Therapeutics Plc (AKTX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Samir Rashmikant Patel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Samir Rashmikant Patel been buying or selling stock?
Recorded transactions: 4 open-market purchases ($344K) and 0 open-market sales across all tracked filings.
